Biotech startups in Wuhan, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Hopson Technology | Wuhan | Series A | $4.1M | 2023-09-27 |
| Frasergen | Wuhan | Series B | $7.5M | 2017-11-12 |
| Haixi Biotechnology | Wuhan | Series A | $1.4M | 2024-08-29 |
3 rows of the CSV in 5 of its 18 columns.
- The 30 biotech startups in Wuhan, China have raised $1.1B in total.
- 6 of them closed their most recent round in the last 12 months, $154.2M combined.
- The largest of those rounds is Neurophth Therapeutics' $97.1M Series D, dated August 2026.
- Health care is the most common other sector, with 23 companies (77%).
- 24% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (32% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
2 of 30| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Boyuan Biotechnology | Boyuan Biotechnology offers a one-stop service platform for animal and plant functional gene research. | Biotech | Series A | $1.4M | 2024-01-05 | Addor Capital | 101 to 250 | 2011 | |
| Hopson Technology | Hopson Technology develops natural product synthesis technology. | Biotech | Series A | $4.1M | 2023-09-27 | $4.1M | Hillhouse Investment, Frees Fund, Hua Capital +1 | 101 to 250 | 2021 |
Table 1. Biotech startups in Wuhan, China: the 2 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 30.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Zhongbo Juli | Private equity firm | Chaoyang, China | 1 | 3% | ||
| 2 | Vertex Ventures China | Venture capital firm | Beijing, China | 1 | 3% | ||
| 3 | Lapam Capital | Venture capital firm | Beijing, China | 1 | 3% | ||
| 4 | Qianhai Fund of Funds | Private equity firm | Shanzhen, China | 1 | 3% | ||
| 5 | Wuyuan Capital | Venture capital firm | Beijing, China | 1 | 3% | ||
| 6 | Frees Fund | Venture capital firm | Beijing, China | 1 | 3% | ||
| 7 | Hua Capital | Private equity firm | Beijing, China | 1 | 3% | ||
| 8 | Hillhouse Investment | Angel group | Singapore | 1 | 3% | ||
| 9 | Addor Capital | Venture capital firm | Nanjing, China | 1 | 3% | ||
| 10 | Source Capital | Private equity firm | Beijing, China | 1 | 3% | ||
| 11 | Rivercity Investment | Hedge fund | Wuhan, China | 1 | 3% |
Table 2. Biotech startups in Wuhan, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 23 | 77% | $854.4M |
| Software | 1 | 3% | $9.0M |
Table 3. Biotech startups in Wuhan, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 1 | 3% | |
| Seed | 9 | 30% | $3.9M |
| Series A | 10 | 33% | $4.1M |
| Series B | 4 | 13% | $7.5M |
| Series C | 4 | 13% | $38.3M |
| Series D+ | 2 | 7% | $189.1M |
Table 4. Biotech startups in Wuhan, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 17% | |
| August 2026 | 1 | 17% | $97.1M |
| July 2026 | 2 | 33% | $38.3M |
| May 2026 | 1 | 17% | $1.4M |
| December 2025 | 1 | 17% | $17.4M |
Table 5. Biotech startups in Wuhan, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 17% | $136.8M |
| 2025 | 4 | 13% | $31.3M |
| 2024 | 6 | 20% | $30.4M |
| 2023 | 3 | 10% | $73.7M |
| 2022 | 1 | 3% | $29.9M |
| 2021 | 3 | 10% | $208.8M |
Table 6. Biotech startups in Wuhan, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 7% |
| 2020 to 2022 | 5 | 17% |
| 2015 to 2019 | 10 | 34% |
| 2010 to 2014 | 11 | 38% |
| Before 2010 | 1 | 3% |
Table 7. Biotech startups in Wuhan, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 3 | 14% |
| 11 to 50 | 7 | 32% |
| 51 to 100 | 4 | 18% |
| 101 to 250 | 6 | 27% |
| 501 to 1,000 | 2 | 9% |
Table 8. Biotech startups in Wuhan, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Wuhan, China. On 16 November 2026 that is 30 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 2 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 30 rows: 9 have no round amount, 0 no city and 12 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Wuhan, China are on the list?
- 30, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 30 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.